The effect of TIPEK(EGF) on the Cultivation of Penaeus Vannamei

Views : 537
Author : Rota
Update time : 2024-12-10 15:27:03

The effect of TIPEK(EGF) on the Cultivation of Penaeus Vannamei

 

1. Objective of the Trial

The purpose of this trial is to add the product "TIPEK(EGF)" to the feed in order to verify its effects in promoting the repair of inTrialinal epithelial damage, growth and development, enhancing the digestive and absorptive capacity of the inTrialine, improving the inTrialinal immune function, comprehensively enhancing the overall health of the animal body, and facilitating growth.

 

2. Trial Period

Trial Timeline: From September 5, 2024, to October 16, 2024

Duration of Trial: Preparation Phase - 19 days; Formal Trial Phase - 23 days

 

3. Trial Design

3.1Trial Materials

Trial Animals: 50-day-old Pacific White Shrimp (Litopenaeus vannamei)

The Trial animals should be of pure genetic lineage, with a clear source, healthy, and of uniform size from the same batch. The sex ratio (male to female) should remain consistent across all replicates.

3.2Trial Groups

Table 1

Items

Treatments

Sample Number

Control Group

Basal Ration

36000×2

Trial Group

Basal Ration+5kg/t 10% TIPEK(EGF)

36000×2

3.3 Trial Management
3.3.1 During the trial, feeding and management practices should adhere to the breeding standards of the aquaculture farm.
3.3.2 The water quality conditions across all replicates should remain consistent.
3.3.3 With the exception of routine immunization procedures synchronized with other shrimp populations, maintaining the trial treatment as the sole variable is the principle to follow.

3.4 Sample Collection and Indicator Measurement
During the trial, shrimp size was regularly measured and marked weekly. After a 24-hour fasting period following the trial, the shrimp were weighed upon harvest from the pond, with a final marking conducted prior to harvest. Feeding records were maintained throughout the trial period. Upon completion of the growth trial, the total weight of shrimp from each replicate trial was tallied, and indicators such as size, average final weight, and survival rate were calculated. Following the trial, three shrimp from each group were randomly selected, individually measured for body length and weighed, and then dissected to remove the hepatopancreas, which was weighed before being placed in a cryopreservation tube. The hepatopancreas weight, body length, and body weight data were used to calculate indicators such as hepatosomatic index (HSI) and condition factor (K).


Method for Measuring Body Length: A ruler was used to measure the length from the base of the shrimp's eyestalk to the end of its tail segment.
Average Final Weight = Marked Weight / Number of Marked Shrimp
Survival Rate = Total Weight / Average Final Weight / 36,000
Size = Number of Marked Shrimp / Marked Weight × 500
Hepatosomatic Index (HSI, %) = 100 × Hepatopancreas Weight / Shrimp Body Weight
Condition Factor (K) = Body Weight / (Body Length)^3
Additionally, photographs of the shrimp's conditions were taken weekly to maintain a health record.

 

4.  Data Processing and Statistical Analysis

The trial data were initially summarized using Excel. The t-Trial analysis of the results was conducted using SPSS 19.0 statistical software (with P < 0.05 indicating a statistically significant difference). The trial data are presented as "mean ± standard deviation."

 

5.  Result and Anaysis

5.1  Surface observation

 

5.2  Growth Index

Table 2 Trial Result

 

Control Group

Trial Group

D-value

Incremental percentage

Initial Size

153.23

158.53

5.3

3.46

Final Size

89.48

89.30

-0.18

-0.20

Growth Size

63.75

69.23

5.48

8.60

Initial Weight/g

3.26

3.15

-0.11

-3.37

Final Weight/g

5.60

5.62

0.02

0.36

Average Weight Gain/g

2.34

2.47

0.13

5.56

Body Length/cm

7.97

8.97

1

12.55

Condition Factor

4.53

6.27

1.74

38.41

Liver-to-Body Ratio%

3.75

6.17

2.42

64.53

Average Feed Intake per Pond/kg

59.55

57.63

-1.92

-3.22

FCR

0.86

0.77

-0.09

-10.47

Survival Rate%

82.08

84.17

2.09

2.55

 

As shown in Table 2, the trial group significantly improved the growth performance of the Pacific white shrimp. Specifically, the growth specification of the trial group was 8.6% higher than that of the control group, and the average weight gain was 5.56% higher. Additionally, the body length, condition factor, and hepatosomatic index of the trial group were 12.55%, 38.41%, and 64.53% higher, respectively, compared to the control group. The survival rate of the trial group was also 2.55% higher. Meanwhile, the feed conversion ratio of the trial group was 10.47% lower than that of the control group.

 

6. Trial Conclusion

The trial group can promote the healthy development of the white shrimp (Litopenaeus vannamei) and significantly improve their growth performance.




Related News
Read More >>
HUADE INSIGHTS | Why What Really Determines a Chick’s Future May Happen Before Hatch, Not After? HUADE INSIGHTS | Why What Really Determines a Chick’s Future May Happen Before Hatch, Not After?
Sep .07.2026
Many people believe that a chick’s growth truly begins the moment it hatches and starts eating feed.
In fact, how fast it grows, how efficiently it converts feed into body weight, and how healthy its gut remains throughout its life are all partly determined before the chick even hatches. If we compare a broiler’s life to a marathon, the final few days of incubation, together with the first 10 days after hatch, are more like the starting phase that can determine the outcome of the race. This is a very short period, yet it is far more important than many people realize.
HUADE BIOTECH VIV Exhibition Recap | We Look Forward to Meeting Again HUADE BIOTECH VIV Exhibition Recap | We Look Forward to Meeting Again
Sep .02.2026
From August 19–21, three days of exhibition came to a successful close.
The HUADE BIOTECH booth stayed lively throughout the show. Cup after cup of tea was served, while visitors picked up our samples, examined them closely, and engaged in in-depth conversations with our team.
We came as promised, and we talked as promised.
Every chair welcomed someone who came with genuine questions, ideas, and interest.
Thank you to everyone who stopped by, took a seat, shared a conversation, and spent time with us.
HUADE INSIGHTS | Is Fish Disease Becoming Harder to Prevent? The Real First Line of Defense May be Lost Not in the Gills, but in Natural Immunity HUADE INSIGHTS | Is Fish Disease Becoming Harder to Prevent? The Real First Line of Defense May be Lost Not in the Gills, but in Natural Immunity
Aug .26.2026
In recent years, a growing body of research on teleost innate immunity has begun to focus on a critical question: 
What determines whether fish are prone to disease is not merely the external environment, but also the fish's own natural defense capacity—i.e., their innate immune competence.
4 Days To Go | Huade Biotech Is Ready For VIV — We’re Waiting To Meet You 4 Days To Go | Huade Biotech Is Ready For VIV — We’re Waiting To Meet You
Aug .14.2026
From August 19–21, the 18th VIV Select China – Asia International Intensive Animal Husbandry Exhibition will take place at the Shanghai World Expo Exhibition & Convention Center.
HUADE BIOTECH is ready to welcome you at Hall H1, Booth B1723. The tea is ready, the samples are on display, and we’re looking forward to meeting you.